SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory field, with the aim of developing...
Hence then, the article about simcere pharmaceutical enters into a research collaboration agreement with stanford medicine to develop innovative therapies for patients with idiopathic pulmonary fibrosis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis )
Also on site :
- Hugh Jackman Reveals How He Survived 8-Hour Transformation to Look Unrecognizable in ‘Death of Robin Hood’
- Nothing Bundt Cakes Gets Patriotic With Summer Desserts Featuring Its No. 1-Selling Flavor
- Coca-Cola’s Iconic Glass Bottle Is Getting an ‘Epic’ New Casio Collectible